CN103690694A - 一种治疗过敏性鼻炎的中药组合物 - Google Patents
一种治疗过敏性鼻炎的中药组合物 Download PDFInfo
- Publication number
- CN103690694A CN103690694A CN201310741613.6A CN201310741613A CN103690694A CN 103690694 A CN103690694 A CN 103690694A CN 201310741613 A CN201310741613 A CN 201310741613A CN 103690694 A CN103690694 A CN 103690694A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- herba
- allergic rhinitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 25
- 206010039085 Rhinitis allergic Diseases 0.000 title claims abstract description 22
- 201000010105 allergic rhinitis Diseases 0.000 title claims abstract description 22
- 241000628997 Flos Species 0.000 claims abstract description 12
- 239000003814 drug Substances 0.000 claims description 47
- 239000008187 granular material Substances 0.000 claims description 12
- 239000000463 material Substances 0.000 claims description 7
- 239000002994 raw material Substances 0.000 claims description 6
- 241000257303 Hymenoptera Species 0.000 claims description 5
- 241000545442 Radix Species 0.000 claims description 5
- 241000405217 Viola <butterfly> Species 0.000 claims description 5
- 238000009472 formulation Methods 0.000 claims description 2
- 241001529739 Prunella <angiosperm> Species 0.000 claims 1
- 244000179560 Prunella vulgaris Species 0.000 abstract description 6
- 241000159213 Zygophyllaceae Species 0.000 abstract description 2
- MUKYLHIZBOASDM-UHFFFAOYSA-N 2-[carbamimidoyl(methyl)amino]acetic acid 2,3,4,5,6-pentahydroxyhexanoic acid Chemical compound NC(=N)N(C)CC(O)=O.OCC(O)C(O)C(O)C(O)C(O)=O MUKYLHIZBOASDM-UHFFFAOYSA-N 0.000 abstract 1
- 241001529821 Agastache Species 0.000 abstract 1
- 241000288784 Barleria cristata Species 0.000 abstract 1
- 241000218691 Cupressaceae Species 0.000 abstract 1
- 241001162994 Rugosus Species 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 230000007012 clinical effect Effects 0.000 abstract 1
- 239000008361 herbal raw material Substances 0.000 abstract 1
- 230000005923 long-lasting effect Effects 0.000 abstract 1
- 235000009165 saligot Nutrition 0.000 abstract 1
- 235000008113 selfheal Nutrition 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 26
- 239000000843 powder Substances 0.000 description 16
- 230000000694 effects Effects 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 239000004375 Dextrin Substances 0.000 description 12
- 229920001353 Dextrin Polymers 0.000 description 12
- 235000019425 dextrin Nutrition 0.000 description 12
- 229940079593 drug Drugs 0.000 description 12
- 238000003756 stirring Methods 0.000 description 12
- 239000000243 solution Substances 0.000 description 9
- 239000012567 medical material Substances 0.000 description 8
- 239000007921 spray Substances 0.000 description 7
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- KUVIULQEHSCUHY-XYWKZLDCSA-N Beclometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(=O)CC)(OC(=O)CC)[C@@]1(C)C[C@@H]2O KUVIULQEHSCUHY-XYWKZLDCSA-N 0.000 description 5
- 229960004495 beclometasone Drugs 0.000 description 5
- 238000004140 cleaning Methods 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 239000003862 glucocorticoid Substances 0.000 description 4
- 210000003928 nasal cavity Anatomy 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000007779 soft material Substances 0.000 description 4
- 238000005507 spraying Methods 0.000 description 4
- 229910001220 stainless steel Inorganic materials 0.000 description 4
- 239000010935 stainless steel Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 206010067484 Adverse reaction Diseases 0.000 description 3
- 230000006838 adverse reaction Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000007922 nasal spray Substances 0.000 description 3
- 229940097496 nasal spray Drugs 0.000 description 3
- 238000012856 packing Methods 0.000 description 3
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 244000046101 Sophora japonica Species 0.000 description 2
- 235000010586 Sophora japonica Nutrition 0.000 description 2
- 239000000739 antihistaminic agent Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000002917 insecticide Substances 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 241001105170 Angelica anomala Species 0.000 description 1
- 206010006482 Bronchospasm Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 241000729173 Cirsium japonicum Species 0.000 description 1
- 244000089795 Clausena lansium Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000125183 Crithmum maritimum Species 0.000 description 1
- 206010013980 Dyssomnias Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010062016 Immunosuppression Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000000592 Nasal Polyps Diseases 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 241000158526 Nasalis Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 235000010674 Prunella vulgaris Nutrition 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 241001533104 Tribulus terrestris Species 0.000 description 1
- 241000256856 Vespidae Species 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 201000009961 allergic asthma Diseases 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 229960003099 amcinonide Drugs 0.000 description 1
- ILKJAFIWWBXGDU-MOGDOJJUSA-N amcinonide Chemical compound O([C@@]1([C@H](O2)C[C@@H]3[C@@]1(C[C@H](O)[C@]1(F)[C@@]4(C)C=CC(=O)C=C4CC[C@H]13)C)C(=O)COC(=O)C)C12CCCC1 ILKJAFIWWBXGDU-MOGDOJJUSA-N 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 230000007885 bronchoconstriction Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000009989 contractile response Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 210000003725 endotheliocyte Anatomy 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 210000003712 lysosome Anatomy 0.000 description 1
- 230000001868 lysosomic effect Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 208000016366 nasal cavity polyp Diseases 0.000 description 1
- 210000002850 nasal mucosa Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 238000010181 skin prick test Methods 0.000 description 1
- 201000002859 sleep apnea Diseases 0.000 description 1
- 230000005586 smoking cessation Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/532—Agastache, e.g. giant hyssop
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/86—Violaceae (Violet family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Insects & Arthropods (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗过敏性鼻炎的中药组合物，该药由如下重量份的中药材原料制备而成：槐花20-30份、露蜂房30-42份、藿香15-22份、蒺藜15-22份、黄柏20-30份、大蓟6-12份、白芷6-12份、蒲公英20-30份、紫花地丁20-30份、夏枯草15-22份。本发明的中药组合物治疗过敏性鼻炎的临床疗效显著，疗效稳定而持久。
Description
技术领域
本发明属于中医药技术领域，具体而言，涉及一种治疗过敏性鼻炎的中药组合物。
背景技术
过敏性鼻炎属鼻腔黏膜和黏膜下组织的炎症，诱发于花粉、真菌、动物皮毛、食物、药物接触、气候变迁等过敏或非特异性刺激。该病具有发作反复和频繁的特点，发病率高、难以根治。很多患者因为嗅觉或睡眠不良导致食欲减退，对工作和生活都会造成极大的影响，如果长期迁延不治，病情就会不断发展，或诱发鼻窦炎、鼻息肉、过敏性哮喘、睡眠呼吸暂停综合征、冠心病、心肌梗死、高血压、脑血管意外等疾病。由于过敏性鼻炎的发病机理还没有完全搞清楚．彻底根治尚难以做到，临床以药物治疗为主，包括口服抗组胺药和鼻腔局部用糖皮质激素喷剂。但是传统抗组胺类治疗药物和有些激素类药存在副作用大、不良反应多的缺点，服药后可能出现便秘、口干、鼻黏膜干燥、痰液变浓等症状，并产生困乏和疲倦，对肝、肾也有损害，严重者还将导致肥胖、感染、色素沉着等病症。所以选择无副作用的中药和不良反应少而疗效好的糖皮质激素类药物联合用药是治疗过敏性鼻炎较好的方案。
丙酸倍氯米松鼻喷雾剂是一种强效局部用糖皮质激素，其药效机制是通过鼻腔内用药，来增强内皮细胞、平滑肌细胞和溶酶体膜的稳定性，抑制免疫反应和降低抗体合成，使组织胺等过敏活性介质的释放减少和活性降低，并降低抗原—抗体结合时激发的酶促过程，抑制支气管收缩物质的合成和释放，降低平滑肌的收缩反应，从而达到治疗过敏性鼻炎的效果，用药后有较好的抗炎作用。相关研究资料显示，该药经鼻腔喷入，每次每鼻孔2揿，每日2次，每揿50μg，其临床有效率达75％以上，但药物不良反应发生率为12％。
如果开发一种副作用较小的中成药，从而协同丙酸倍氯米松在不降低效疗的情况下减小副作用的发生率，这显得非常重要。
发明内容
鉴于糖皮质激素等西药存在较大的副作用，本发明的目的在于提供一种治疗过敏性鼻炎的中药组合物，从而配合低剂量西药用药，不仅降低了不良反应发生率，而且提高了疾病治疗效果。
本发明的目的是这样实现的：
一种治疗过敏性鼻炎的中药组合物，由如下重量份的中药材原料制备而成：槐花20-30份、露蜂房30-42份、藿香15-22份、蒺藜15-22份、黄柏20-30份、大蓟6-12份、白芷6-12份、蒲公英20-30份、紫花地丁20-30份、夏枯草15-22份。
优选地，如上所述治疗过敏性鼻炎的中药组合物，它由如下重量份的中药材原料制备而成：槐花23-27份、露蜂房34-38份、藿香17-20份、蒺藜17-20份、黄柏23-27份、大蓟8-10份、白芷8-10份、蒲公英23-27份、紫花地丁23-27份、夏枯草17-20份。
在本发明的一个最优选的实施例中，如上所述的中药组合物由如下重量份的中药材原料制备而成：槐花25份、露蜂房36份、藿香18份、蒺藜18份、黄柏25份、大蓟8份、白芷8份、蒲公英25份、紫花地丁25份、夏枯草18份。
优选地，上述的治疗过敏性鼻炎的中药组合物是口服制剂。
再进一步优选地，上述的治疗过敏性鼻炎的中药组合物是颗粒剂。
本发明涉及的中药材具有如下来源：槐花选用豆科植物槐（Sophora japonica L.）的干燥花朵；露蜂房选用胡蜂科昆虫黄星长脚黄蜂或多种近缘昆虫的巢；藿香选用唇形科植物藿香的干燥茎叶蒺藜选用蒺藜科植物蒺藜Tribulus terrestris L.的干燥成熟果实；黄柏选自芸香科植物黄皮树或黄檗的干燥树皮；白芷选用伞形科植物川白芷的根；大蓟选自菊科植物蓟Cirsium japonicum DC. 的干燥地上部分；蒲公英选自干燥蒲公英的全草；紫花地丁选用紫花地丁的干燥全草；夏枯草选用唇形科植物夏枯草 Prunella vulgaris L. 的干燥果穗。
将上述各中药材制备成本发明的复方颗粒剂的制备方法，包括如下步骤：按处方量称取清洗干净的槐花、露蜂房、藿香、蒺藜、黄柏、大蓟、白芷、蒲公英、紫花地丁和夏枯草，合并，加水煎煮两次，第一次加水为药材重量的10倍量，煎煮1.5h，第二次加水为药材重量的8倍量，煎煮1.5h，合并煎液，0.07MPa、60-70℃下减压浓缩至65℃时相对密度为1.15的浸膏，加95%(v/v)乙醇使含醇量达75%(v/v)， 搅拌，静置24小时，过滤，滤液在0.07MPa、65℃条件下减压浓缩成至65℃时相对密度为1.25，并回收乙醇，得浓缩液，将浓缩液喷雾干燥（条件为进风温度为100℃，出风温度为80℃，物料温度为80℃， 雾化压力为0.2兆帕，喷雾速度为5ml/s。），粉碎过80目筛，得到清膏粉；按照清膏粉：糊精1：1-3的重量比称取清膏粉、糊精，将清膏粉与糊精投入槽型混合机中，搅拌20分钟，边搅拌边缓缓加入适量乙醇溶液，至制成软材，用12目不锈钢筛制粒，65-75℃干燥2小时，取出，放凉即得所述的颗粒剂。
本发明的中药组合物治疗过敏性鼻炎的临床疗效显著，相对于西药作用快却在药物疗效过后症状多复发的特点，本发明的中药方剂具有治疗作用慢但疗效稳定而持久的优点，可与西药联用而降低西药用药量来减少不良反应发生率。
具体实施方式
以下是本发明的具体实施例，对本发明的技术方案做进一步作描述，但是本发明的保护范围并不限于这些实施例。凡是不背离本发明构思的改变或等同替代均包括在本发明的保护范围之内。
实施例1
生药处方：槐花25份、露蜂房36份、藿香18份、蒺藜18份、黄柏25份、大蓟8份、白芷8份、蒲公英25份、紫花地丁25份、夏枯草18份。
制备工艺：按处方量称取清洗干净的上述中药材，合并，加水煎煮两次，第一次加水为药材重量的10倍量，煎煮1.5h，第二次加水为药材重量的8倍量，煎煮1.5h，合并煎液，0.07MPa、60-70℃下减压浓缩至65℃时相对密度为1.15的浸膏，加95%(v/v)乙醇使含醇量达75%(v/v)， 搅拌，静置24小时，过滤，滤液在0.07MPa、65℃条件下减压浓缩成至65℃时相对密度为1.25，并回收乙醇，得浓缩液，将浓缩液喷雾干燥（条件为进风温度为100℃，出风温度为80℃，物料温度为80℃， 雾化压力为0.2兆帕，喷雾速度为5ml/s。），粉碎过80目筛，得到清膏粉；按照清膏粉：糊精1：2.5的重量比称取清膏粉、糊精，将清膏粉与糊精投入槽型混合机中，搅拌20分钟，边搅拌边缓缓加入55%乙醇，至制成软材，用12目不锈钢筛制粒，65-75℃干燥2小时，取出，放凉即得所述的颗粒剂，按每袋15g包装。
实施例2
生药处方：槐花22份、露蜂房42份、藿香20份、蒺藜20份、黄柏30份、大蓟10份、白芷10份、蒲公英23份、紫花地丁27份、夏枯草22份。
制备工艺：按处方量称取清洗干净的上述中药材，合并，加水煎煮两次，第一次加水为药材重量的10倍量，煎煮1.5h，第二次加水为药材重量的8倍量，煎煮1.5h，合并煎液，0.07MPa、60-70℃下减压浓缩至65℃时相对密度为1.15的浸膏，加95%(v/v)乙醇使含醇量达75%(v/v)， 搅拌，静置24小时，过滤，滤液在0.07MPa、65℃条件下减压浓缩成至65℃时相对密度为1.25，并回收乙醇，得浓缩液，将浓缩液喷雾干燥（条件为进风温度为100℃，出风温度为80℃，物料温度为80℃， 雾化压力为0.2兆帕，喷雾速度为5ml/s。），粉碎过80目筛，得到清膏粉；按照清膏粉：糊精1：3的重量比称取清膏粉、糊精，将清膏粉与糊精投入槽型混合机中，搅拌20分钟，边搅拌边缓缓加入55%乙醇，至制成软材，用12目不锈钢筛制粒，65-75℃干燥2小时，取出，放凉即得所述的颗粒剂，按每袋15g包装。
实施例3
生药处方：槐花30份、露蜂房30份、藿香22份、蒺藜15份、黄柏23份、大蓟6份、白芷8份、蒲公英28份、紫花地丁30份、夏枯草17份。
制备工艺：按处方量称取清洗干净的上述中药材，合并，加水煎煮两次，第一次加水为药材重量的10倍量，煎煮1.5h，第二次加水为药材重量的8倍量，煎煮1.5h，合并煎液，0.07MPa、60-70℃下减压浓缩至65℃时相对密度为1.15的浸膏，加95%(v/v)乙醇使含醇量达75%(v/v)， 搅拌，静置24小时，过滤，滤液在0.07MPa、65℃条件下减压浓缩成至65℃时相对密度为1.25，并回收乙醇，得浓缩液，将浓缩液喷雾干燥（条件为进风温度为100℃，出风温度为80℃，物料温度为80℃， 雾化压力为0.2兆帕，喷雾速度为5ml/s。），粉碎过80目筛，得到清膏粉；按照清膏粉：糊精1：3的重量比称取清膏粉、糊精，将清膏粉与糊精投入槽型混合机中，搅拌20分钟，边搅拌边缓缓加入55%乙醇，至制成软材，用12目不锈钢筛制粒，65-75℃干燥2小时，取出，放凉即得所述的颗粒剂，按每袋15g包装。
实施例4 中药颗粒剂对过敏性鼻炎患者的疗效研究
63例确诊的过敏性鼻炎患者，男35例，女28例，年龄16～63岁，平均37.1±8.6岁，病程半年至12年。所有患者均连续3个月以上有鼻塞、鼻痒、流清水样鼻涕、打喷嚏等症状，鼻腔检查可见黏膜苍白水肿或鼻甲充血肿胀，变应原皮肤点刺试验呈阳性，特异性IgE抗体检测呈阳性。将患者随机分为两组，其中试验组32例，对照组31例，两组患者的性别、年龄、病程等基本资料比较，无显著行差异，具有可比性。
对照组患者单纯使用丙酸倍氯米松鼻喷雾剂(葛兰素史克生产，商品名：伯克纳，规格50μg*200揿)，每天早晚各1次，每次每鼻孔1揿，连用1个月为1个疗程。喷鼻后适当用淡盐水清洗鼻腔。试验组在使用丙酸倍氯米松鼻喷雾剂药物的基础上，冲服中药颗粒剂（按照本发明实施例1的处方和工艺制备而成）2袋/d，早晚各一袋，连续用药1个月。治疗期间不使用其他治疗方法，戒烟限酒，少吃辛辣油腻食物。治疗结束后，按如下标准统计疗效：
显效：临床症状及体征基本消失，半年以上无复发；
有效：临床症状基本消失．体征明显减轻，偶有复发；
无效：临床症状体征与治疗前相比无明显改变或加重。
治疗结束后，随访6-9个月并统计各组疗效，具体试验结果参见表1。
表1 两组疗效情况比较
Claims (5)
1.一种治疗过敏性鼻炎的中药组合物，其特征在于：所述的中药组合物由如下重量份的中药材原料制备而成：槐花20-30份、露蜂房30-42份、藿香15-22份、蒺藜15-22份、黄柏20-30份、大蓟6-12份、白芷6-12份、蒲公英20-30份、紫花地丁20-30份、夏枯草15-22份。
2.根据权利要求1所述的治疗过敏性鼻炎的中药组合物，其特征在于：所述的中药组合物由如下重量份的中药材原料制备而成：槐花23-27份、露蜂房34-38份、藿香17-20份、蒺藜17-20份、黄柏23-27份、大蓟8-10份、白芷8-10份、蒲公英23-27份、紫花地丁23-27份、夏枯草17-20份。
3.根据权利要求2所述治疗过敏性鼻炎的中药组合物，其特征在于：所述的中药组合物由如下重量份的中药材原料制备而成：槐花25份、露蜂房36份、藿香18份、蒺藜18份、黄柏25份、大蓟8份、白芷8份、蒲公英25份、紫花地丁25份、夏枯草18份。
4.根据权利要求1或2或3所述治疗过敏性鼻炎的中药组合物，其特征在于：所述的中药组合物是口服制剂。
5.根据权利要求1或2或3所述治疗过敏性鼻炎的中药组合物，其特征在于：所述的中药组合物是颗粒剂。
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310741613.6A CN103690694B (zh) | 2013-12-30 | 2013-12-30 | 一种治疗过敏性鼻炎的中药组合物 |
| CN201610026579.8A CN105596571A (zh) | 2013-12-30 | 2013-12-30 | 一种制备治疗过敏性鼻炎的中药组合物颗粒剂的方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310741613.6A CN103690694B (zh) | 2013-12-30 | 2013-12-30 | 一种治疗过敏性鼻炎的中药组合物 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610026579.8A Division CN105596571A (zh) | 2013-12-30 | 2013-12-30 | 一种制备治疗过敏性鼻炎的中药组合物颗粒剂的方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103690694A true CN103690694A (zh) | 2014-04-02 |
| CN103690694B CN103690694B (zh) | 2016-01-06 |
Family
ID=50352464
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610026579.8A Withdrawn CN105596571A (zh) | 2013-12-30 | 2013-12-30 | 一种制备治疗过敏性鼻炎的中药组合物颗粒剂的方法 |
| CN201310741613.6A Active CN103690694B (zh) | 2013-12-30 | 2013-12-30 | 一种治疗过敏性鼻炎的中药组合物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610026579.8A Withdrawn CN105596571A (zh) | 2013-12-30 | 2013-12-30 | 一种制备治疗过敏性鼻炎的中药组合物颗粒剂的方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (2) | CN105596571A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105255676A (zh) * | 2015-11-09 | 2016-01-20 | 张卫国 | 枸杞酒及其制备方法和应用 |
| CN107648386A (zh) * | 2017-11-13 | 2018-02-02 | 江苏华晶生物科技有限公司 | 一种具有水飞蓟治疗过敏性鼻炎、哮喘的中药组合物 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101700280A (zh) * | 2009-11-11 | 2010-05-05 | 丁常燕 | 一种治疗过敏性鼻炎的中药 |
| CN103432475A (zh) * | 2013-09-06 | 2013-12-11 | 梁怡芃 | 一种治疗过敏性鼻炎的中药组合物及其制备方法 |
-
2013
- 2013-12-30 CN CN201610026579.8A patent/CN105596571A/zh not_active Withdrawn
- 2013-12-30 CN CN201310741613.6A patent/CN103690694B/zh active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101700280A (zh) * | 2009-11-11 | 2010-05-05 | 丁常燕 | 一种治疗过敏性鼻炎的中药 |
| CN103432475A (zh) * | 2013-09-06 | 2013-12-11 | 梁怡芃 | 一种治疗过敏性鼻炎的中药组合物及其制备方法 |
Non-Patent Citations (1)
| Title |
|---|
| 黄桂锋等: "过敏性鼻炎的中医药治疗进展", 《甘肃中医》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105255676A (zh) * | 2015-11-09 | 2016-01-20 | 张卫国 | 枸杞酒及其制备方法和应用 |
| CN107648386A (zh) * | 2017-11-13 | 2018-02-02 | 江苏华晶生物科技有限公司 | 一种具有水飞蓟治疗过敏性鼻炎、哮喘的中药组合物 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103690694B (zh) | 2016-01-06 |
| CN105596571A (zh) | 2016-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101181559B (zh) | 治疗真菌类皮肤病的中药制剂的制备方法 | |
| Musthaba et al. | Patented herbal formulations and their therapeutic applications | |
| CN103142860B (zh) | 一种治疗肺结核的苗药 | |
| CN101569712B (zh) | 一种治疗感冒风寒的中药组合物 | |
| CN101152509A (zh) | 一种治疗慢性咽炎的中药制剂的制备方法 | |
| CN103690694B (zh) | 一种治疗过敏性鼻炎的中药组合物 | |
| CN102228531B (zh) | 一种治疗口腔溃疡的中药组合物 | |
| CN111358906B (zh) | 一种适用于外感症的中药组合物 | |
| CN101361857B (zh) | 一种鼻腔表面制剂 | |
| CN107496618A (zh) | 一种治疗感冒、发热的中药组合物及其制备方法 | |
| CN100349596C (zh) | 一种治疗咳喘的药物颗粒 | |
| CN102784300A (zh) | 一种治疗牙痛的药物组合物及其制备方法 | |
| CN102357127A (zh) | 一种治疗流行性感冒的中药 | |
| CN100496572C (zh) | 一种中药组合物及其制备方法 | |
| CN101721437B (zh) | 用于治疗慢性咽炎的药物组合物的制备方法 | |
| CN103446564A (zh) | 一种抗菌消炎的中药组合物及其制备方法 | |
| CN107260915A (zh) | 一种用于牙疼上火的中药配方颗粒及其制备方法 | |
| CN1730086A (zh) | 咳喘膏及其制法 | |
| CN103446433A (zh) | 一种用于去除口腔异味的中药有效部位组合物及其制备方法 | |
| CN103784633B (zh) | 一种治疗小儿鼻炎的中药组合物及其制备方法 | |
| CN116763834A (zh) | 一种治疗关节痛的中药组合物、制剂及制备方法和应用 | |
| CN103623203A (zh) | 一种咳舒口服制剂的制备方法 | |
| CN103099851A (zh) | 一种治疗感冒的药物组合物和制备方法 | |
| CN102895429B (zh) | 一种治疗过敏性鼻炎的中药组合物及其制备方法 | |
| WO2012129957A1 (zh) | 几种药物配方 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20151208 Address after: 276017 Shandong city of Linyi province high tech Zone Technology Park Road bimonthly A321 Linyi grass beauty medicine science and Technology Co Ltd Applicant after: Yang Xianmei Applicant after: Zhang Xia Address before: 266200 Jimo, Qingdao, the Yellow River, No. two, No. Road, building 25, building 182 Applicant before: Wang Xueyan |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20160721 Address after: 276017 Shandong city of Linyi province high tech Zone Technology Park Road bimonthly A321 Linyi grass beauty medicine science and Technology Co Ltd Patentee after: Yang Xianmei Address before: 276017 Shandong city of Linyi province high tech Zone Technology Park Road bimonthly A321 Linyi grass beauty medicine science and Technology Co Ltd Patentee before: Yang Xianmei Patentee before: Zhang Xia |
|
| CB03 | Change of inventor or designer information |
Inventor after: Zhang Xia Inventor after: Gu Xiao Inventor before: Zhang Xia |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20170526 Address after: 226000, 9 Jiangsu Road, Binjiang fine chemical industry zone, Nantong, Jiangsu, Qidong Patentee after: NANTONG FINC PHARMACEUTICAL CHEMICAL Co.,Ltd. Address before: 276017 Shandong city of Linyi province high tech Zone Technology Park Road bimonthly A321 Linyi grass beauty medicine science and Technology Co Ltd Patentee before: Yang Xianmei |
|
| CP03 | Change of name, title or address | ||
| CP03 | Change of name, title or address |
Address after: 226000, No.78 Jiangsu Road, Binjiang Fine Chemical Industrial Park, Qidong City, Nantong City, Jiangsu Province Patentee after: Nantong Fayink High-tech Material Technology Co.,Ltd. Address before: 226000 9 Jiangsu Road, Binjiang Fine Chemical Industrial Park, Qidong, Nantong, Jiangsu Patentee before: NANTONG FINC PHARMACEUTICAL CHEMICAL Co.,Ltd. |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20231208 Address after: 226000 Qidong Binjiang fine chemical industry park, Nantong City, Jiangsu Province Patentee after: Qidong Binhua water supply Co.,Ltd. Address before: 226000, No.78 Jiangsu Road, Binjiang Fine Chemical Industrial Park, Qidong City, Nantong City, Jiangsu Province Patentee before: Nantong Fayink High-tech Material Technology Co.,Ltd. |